Portopulmonary hypertension: Hemodynamics, pulmonary angiography, and configuration of the heart

Circulation Journal

Volumn 69, Issue 11, 2005, Pages 1386-1393

  Sakuma, Masahito ^a   Souma, Shinko ^a   Kitamukai, Osamu ^a   Demachi, Jun ^a   Takahashi, Tohru ^a   Suzuki, Jun ^a   Nawata, Jun ^a   Sugimura, Kouichiro ^a   Oikawa, Minako ^a   Saji, Kenya ^a   Tada, Tomohiro ^a   Fukui, Shigefumi ^a   Kagaya, Yutaka ^a   Watanabe, Jun ^a   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain natriuretic peptide; Electron beam tomography; Idiopathic pulmonary arterial hypertension; Portopulmonary hypertension; Pulmonary angiography

Indexed keywords

ADULT; ARTERY DILATATION; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE MASS; HEART VENTRICLE VOLUME; HEMODYNAMIC MONITORING; HUMAN; LIVER DYSFUNCTION; LUNG ANGIOGRAPHY; MALE; PORTAL HYPERTENSION; PORTOPULMONARY HYPERTENSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTOLE;

ADULT; AGED; ANGIOGRAPHY; FEMALE; HEART; HEART VENTRICLES; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY ARTERY; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 27644598495     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1386     Document Type: Article

References (47)

1. Kuo PC, Plotkin JS, Johnson LB, Howell CD, Laurin JM, Bartlett ST, et al. Distinctive clinical features of portopulmonary hypertension. Chest 1997; 112: 980-986.
2. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100: 520-528.
3. Herve P, Lebrec D, Brenot F, Simmonneau G, Humbert M, Sitbon O, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11: 1153-1166.
4. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietromi MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
5. Nakayama Y, Nakanishi N, Sugimachi M, Takaki H, Kyotani S, Satoh T, et al. Characteristics of pulmonary artery pressure waveform for differential diagnosis of chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol 1997; 29: 1311-1316.
6. Hajduczok ZD, Weiss RM, Stanford W, Marcus ML. Determination of right ventricular mass in humans and dogs with ultrafast cardiac computed tomography. Circulation 1990; 82: 202-212.
7. Roig ER, Georgiou D, Chomka EV, Wolfkiel C, LoGalbo-Zac C, Rich S, et al. Reproducibility of left ventricular myocardial volume and mass measurements by ultrafast computed tomography. J Am Coll Cardiol 1991; 18: 990-996.
8. Nootens M, Wolfkiel CJ, Chomka EV, Rich S. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol 1995; 75: 374-377.
9. Bardeen CR. Determination of the size of the heart by means of X-rays. Am J Anat 1918; 23: 423-487.
10. Rackley CE, Dodge HT, Coble YD, Hay RE. A method for determining left ventricular mass in man. Circulation 1964; 29: 666-671.
11. Perlmutt LM, Braun SD, Newman GE, Oke EJ, Dunnick NR. Pulmonary arteriography in the high-risk patient. Radiology 1987; 162: 187-189.
12. Hudson ER, Smith TP, McDermott VG, Newman GE, Suhocki PV, Payne CS, et al. Pulmonary angiography performed with iopamidol: Complications in 1434 patients. Radiology 1996; 198: 61-65.
13. Zuckerman DA, Sterling KM, Oser RF. Safety of pulmonary angiography in the 1990's. J Vasc Interv Radiol 1996; 7: 199-205.
14. Bell ALL, Shimomura S, Guthrie WJ, Hempel HF, Fitzpatrick HF, Begg CF. Wedged pulmonary angiography: Its application in congenital and acquired heart disease. Radiology 1959; 73: 566-573.
15. Anderson G, Reid L, Simon G. The radiographic appearances in primary and in thromboembolic pulmonary hypertension. Clin Radiol 1973; 24: 113-120.
16. Bookstein JJ, Silver TM. The angiographic differential diagnosis of acute pulmonary embolism. Radiology 1974; 110: 25-33.
17. Pietra GG. The pathology of primary pulmonary hypertension. In: Rubin LJ, Rich S, editors. Primary pulmonary hypertension. New York: Marcel Dekker Inc; 1997; 19-61.
18. Edwards BS, Weir EK, Edwards WD, Ludwig J, Dykoski RK, Edwards JE. Coexistent pulmonary and portal hypertension: Morphologic and clinical features. J Am Coll Cardiol 1987; 10: 1233-1238.
19. Krowka MJ, Edwards WD. A spectrum of pulmonary vascular pathology in portopulmonary hypertension. Liver Transpl 2000; 6: 241-242.
20. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363: 1461-1468.
21. Mogelvang J, Stubgaard M, Thomsen C, Henriksen O. Evaluation of right ventricular volumes measured by magnetic resonance imaging. Eur Heart J 1988; 9: 529-533.
22. Boxt LM, Katz J, Kolb T, Czegledy FP, Barst RJ. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992; 19: 1508-1515.
23. Katz J, Whang J, Boxt LM, Barst RJ. Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging. J Am Coll Cardiol 1993; 21: 1475-1481.
24. Mochizuki T, Murase K, Higashino H, Koyama Y, Doi M, Miyagawa M, et al. Two- and three-dimensional CT ventriculography: A new application of herical CT. Am J Radiol 2000; 174: 203-208.
25. Lembcke A, Dohmen PM, Dewey M, Klessen C, Elgeti T, Hermann KA, et al. Multislice computed tomography for preoperative evaluation of right ventricular volumes and function: Comparison with magnetic resonance imaging. Ann Thorac Surg 2005; 79: 1344-1351.
26. Nootens M, Wolfkiel CJ, Chomka EV, Rich S. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol 1995; 75: 374-377.
27. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208.
28. Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-870.
29. Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 35S-62S.
30. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: Natural history and the importance of thrombosis. Circulation 1984; 70: 580-587.
31. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
32. Frank H, Mlczoch J, Huber K, Schuster E, Gurtner HP, Kneussl M. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 1997; 91: 714-721.
33. Ogawa A, Matsubara H, Fujio H, Miyaji K, Nakamura K, Morita H, et al. Risk of alveolar hemorrhage in patients with primary pulmonary hypertension: Anticoagulation and epoprostenol therapy. Circ J 2005; 69: 216-220.
34. Camici M, Evangelisti L. Prostacyclin and heparin during haemodialysis: Comparative effects. Life Support Syst 1986; 4: 205-209.
35. Swartz RD, Flamenbaum W, Dubrow A, Hall JC, Crow JW, Cato A. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: Preventing further bleeding complications. J Clin Pharmacol 1988; 28: 818-825.
36. Davenport A, Will EJ, Davison AM. The effect of prostacyclin on intracranial pressure in patients with acute hepatic and renal failure. Clin Nephrol 1991; 35: 151-157.
37. Camici M, Giordani R, Morelli E, Meriggioli M, Balestri PL, Barsotti G, et al. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin. Minerva Med 1998; 89: 405-409.
38. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788.
39. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: The impact of epoprostenol therapy. Circulation 2002; 106: 1477-1482.
40. Takahashi T, Sakuma M, Ikeda J, Nawata J, Demachi J, Kitanukai O, et al. Effects and problems of continuous infusion of epoprostenol for patients with primary pulmonary hypertension. Intern Med 2002; 41: 784-788.
41. Sasayama S, Kunieda T, Tomoike H, Matsuzaki M, Shirato K, Kuriyama T, et al. Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension. Circ J 2005; 69: 131-137.
42. Kataoka M, Satoh T, Manabe T, Anzai T, Yoshioka T, Mitamura H, et al. Oral sildenafil improves primary pulmonary hypertension refractory to epoprostenol. Circ J 2005; 69: 461-465.
43. Rovalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: Analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 1991; 17: 492-498.
44. Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labor and Welfare. Vital statistics of Japan, 2002. Tokyo: The Ministry; 2004.
45. Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labor and Welfare. Patient survey 2002 (all Japan), Vol. I. Tokyo: The Ministry; 2004.
46. McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: Are they related? Am Rev Respir Dis 1983; 127: 437-441.
47. Hashimoto S, Tatsumi K, Okada O, Tanabe N, Kimura H, Kuriyama T, et al. Estimated numbers of patients with intractable respiratory diseases. Nihon Kokyuki Gakkai Zasshi 1998; 36: 1006-1010 (in Japanese).